Correlation between primary chemo- and radiation sensitivity in a panel of highly malignant human soft tissue sarcoma xenografts

被引:9
作者
Budach, W [1 ]
Budach, V [1 ]
Dinges, S [1 ]
Stuschke, M [1 ]
Sack, H [1 ]
机构
[1] UNIV ESSEN GESAMTHSCH, DEPT RADIAT ONCOL, ESSEN, GERMANY
关键词
radiation sensitivity; chemosensitivity; sarcoma; xenograft; nude mice;
D O I
10.1016/S0167-8140(96)01840-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Sensitivity to radiation and sensitivity to cytotoxic drugs have been proposed to be independent properties of tumour cells. However, very few clinical or experimental studies have tested this hypothesis. Therefore, we evaluated the response to ionizing radiation and to four cytotoxic drugs in a panel of 12 human soft tissue sarcoma cell lines using the xenograft system. Material and methods: NMRI-nu/nu nude mice with subcutaneous tumours received at a tumour volume of 120-200 mm(3) either single dose, single agent chemotherapy with 350 mg/kg ifosfamide, 200 mg/kg dacarbazine, 10 mg/kg doxorubicin, 6.6 mg/kg cisplatin, or 24 Gy local tumour irradiation under acutely hypoxic conditions from a cobalt-60 source. Tumour response to radiotherapy and chemotherapy was measured as specific growth delay (SGD). Results: A significant correlation was found between SGD after radiotherapy and SGD after dacarbazine (P < 0.001) and doxorubicin (P = 0.05), whereas no correlation could be demonstrated for cisplatin. For ifosfamide, the correlation reached borderline significance. The maximal response to any of the four tested chemotherapeutic drugs correlated very well with the response to radiotherapy (P < 0.001). Conclusion: The results suggest that radiation sensitivity and chemosensitivity are not independent properties of soft tissue sarcoma cell lines. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 22 条
[1]  
BEHRENS BC, 1987, CANCER RES, V47, P414
[2]   INTERACTION OF TOPOISOMERASE-I INHIBITORS WITH RADIATION IN CIS-DIAMMINEDICHLOROPLATINUM(II)-SENSITIVE AND CIS-DIAMMINEDICHLOROPLATINUM(II)-RESISTANT CELLS-INVITRO AND IN THE FSAIIC FIBROSARCOMA INVIVO [J].
BOSCIA, RE ;
KORBUT, T ;
HOLDEN, SA ;
ARA, G ;
TEICHER, BA .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (01) :118-123
[3]   INDUCTION CHEMOTHERAPY IN ADVANCED HEAD AND NECK-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED STUDY [J].
BRUNIN, F ;
RODRIGUEZ, J ;
JAULERRY, C ;
JOUVE, M ;
PONTVERT, D ;
POINT, D ;
MOSSERI, V ;
POUILLART, P ;
ASSELAIN, B ;
BRUGERE, J ;
BATAINI, JP .
ACTA ONCOLOGICA, 1989, 28 (01) :61-65
[4]   EFFICACY OF IFOSFAMIDE, DACARBAZINE, DOXORUBICIN AND CISPLATIN IN HUMAN SARCOMA XENOGRAFTS [J].
BUDACH, W ;
BUDACH, V ;
STUSCHKE, M ;
SCHMAUDER, B ;
REIPKE, P ;
SCHEULEN, ME .
BRITISH JOURNAL OF CANCER, 1994, 70 (01) :29-34
[5]   THE TCD50 AND REGROWTH DELAY ASSAY IN HUMAN TUMOR XENOGRAFTS - DIFFERENCES AND IMPLICATIONS [J].
BUDACH, W ;
BUDACH, V ;
STUSCHKE, M ;
DINGES, S ;
SACK, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 25 (02) :259-268
[6]  
ENSLEY JF, 1984, CANCER, V54, P811, DOI 10.1002/1097-0142(19840901)54:5<811::AID-CNCR2820540508>3.0.CO
[7]  
2-E
[8]  
ERWIN TJ, 1981, LARYNGOSCOPE, V91, P1181
[9]  
GLICK JH, 1980, CANCER, V46, P1919
[10]  
GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727